186 related articles for article (PubMed ID: 15811878)
1. p53 is a suppressor of inflammatory response in mice.
Komarova EA; Krivokrysenko V; Wang K; Neznanov N; Chernov MV; Komarov PG; Brennan ML; Golovkina TV; Rokhlin OW; Kuprash DV; Nedospasov SA; Hazen SL; Feinstein E; Gudkov AV
FASEB J; 2005 Jun; 19(8):1030-2. PubMed ID: 15811878
[TBL] [Abstract][Full Text] [Related]
2. Diarctigenin, a lignan constituent from Arctium lappa, down-regulated zymosan-induced transcription of inflammatory genes through suppression of DNA binding ability of nuclear factor-kappaB in macrophages.
Kim BH; Hong SS; Kwon SW; Lee HY; Sung H; Lee IJ; Hwang BY; Song S; Lee CK; Chung D; Ahn B; Nam SY; Han SB; Kim Y
J Pharmacol Exp Ther; 2008 Nov; 327(2):393-401. PubMed ID: 18694995
[TBL] [Abstract][Full Text] [Related]
3. Requirement for STAT1 in LPS-induced gene expression in macrophages.
Ohmori Y; Hamilton TA
J Leukoc Biol; 2001 Apr; 69(4):598-604. PubMed ID: 11310846
[TBL] [Abstract][Full Text] [Related]
4. Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice.
Cepinskas G; Katada K; Bihari A; Potter RF
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G184-91. PubMed ID: 17991708
[TBL] [Abstract][Full Text] [Related]
5. Deregulated manganese superoxide dismutase expression and resistance to oxidative injury in p53-deficient cells.
Pani G; Bedogni B; Anzevino R; Colavitti R; Palazzotti B; Borrello S; Galeotti T
Cancer Res; 2000 Aug; 60(16):4654-60. PubMed ID: 10969820
[TBL] [Abstract][Full Text] [Related]
6. Additive effect between NF-kappaB subunits and p53 protein for transcriptional activation of human p53 promoter.
Benoit V; Hellin AC; Huygen S; Gielen J; Bours V; Merville MP
Oncogene; 2000 Sep; 19(41):4787-94. PubMed ID: 11032029
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
8. Wild type p53 functions as a control protein in the differentiation pathway of the B-cell lineage.
Aloni-Grinstein R; Zan-Bar I; Alboum I; Goldfinger N; Rotter V
Oncogene; 1993 Dec; 8(12):3297-305. PubMed ID: 8247532
[TBL] [Abstract][Full Text] [Related]
9. p53 short peptide (p53pep164) regulates lipopolysaccharide-induced tumor necrosis factor-alpha factor/cytokine expression.
Tang X; Molina M; Amar S
Cancer Res; 2007 Feb; 67(3):1308-16. PubMed ID: 17283168
[TBL] [Abstract][Full Text] [Related]
10. Suppression of TLR4-mediated inflammatory response by macrophage class A scavenger receptor (CD204).
Ohnishi K; Komohara Y; Fujiwara Y; Takemura K; Lei X; Nakagawa T; Sakashita N; Takeya M
Biochem Biophys Res Commun; 2011 Aug; 411(3):516-22. PubMed ID: 21756882
[TBL] [Abstract][Full Text] [Related]
11. Expression of prostate specific antigen (PSA) is negatively regulated by p53.
Gurova KV; Roklin OW; Krivokrysenko VI; Chumakov PM; Cohen MB; Feinstein E; Gudkov AV
Oncogene; 2002 Jan; 21(1):153-7. PubMed ID: 11791186
[TBL] [Abstract][Full Text] [Related]
12. Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-kappaB and MAPKs activation in lipopolysaccharide-induced RAW 264.7 macrophage.
Kim HG; Yoon DH; Lee WH; Han SK; Shrestha B; Kim CH; Lim MH; Chang W; Lim S; Choi S; Song WO; Sung JM; Hwang KC; Kim TW
J Ethnopharmacol; 2007 Dec; 114(3):307-15. PubMed ID: 17936530
[TBL] [Abstract][Full Text] [Related]
13. Caffeic acid phenethyl ester-mediated Nrf2 activation and IkappaB kinase inhibition are involved in NFkappaB inhibitory effect: structural analysis for NFkappaB inhibition.
Lee Y; Shin DH; Kim JH; Hong S; Choi D; Kim YJ; Kwak MK; Jung Y
Eur J Pharmacol; 2010 Sep; 643(1):21-8. PubMed ID: 20599928
[TBL] [Abstract][Full Text] [Related]
14. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function.
Zheng SJ; Lamhamedi-Cherradi SE; Wang P; Xu L; Chen YH
Diabetes; 2005 May; 54(5):1423-8. PubMed ID: 15855329
[TBL] [Abstract][Full Text] [Related]
16. RelB inhibits cell proliferation and tumor growth through p53 transcriptional activation.
Jacque E; Billot K; Authier H; Bordereaux D; Baud V
Oncogene; 2013 May; 32(21):2661-9. PubMed ID: 22777360
[TBL] [Abstract][Full Text] [Related]
17. p53 peptide prevents LITAF-induced TNF-alpha-mediated mouse lung lesions and endotoxic shock.
Tang X; O'Reilly A; Asano M; Merrill JC; Yokoyama KK; Amar S
Curr Mol Med; 2011 Aug; 11(6):439-52. PubMed ID: 21663590
[TBL] [Abstract][Full Text] [Related]
18. JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells.
Das A; Chai JC; Jung KH; Das ND; Kang SC; Lee YS; Seo H; Chai YG
Exp Cell Res; 2014 Nov; 328(2):361-78. PubMed ID: 25193078
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of p53 transcriptional programs in B cells upon exposure to genotoxic stress in vivo.
Tonelli C; Morelli MJ; Bianchi S; Rotta L; Capra T; Sabò A; Campaner S; Amati B
Oncotarget; 2015 Sep; 6(28):24611-26. PubMed ID: 26372730
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the Mdr1 isoforms in a p53-deficient mouse model.
Bush JA; Li G
Carcinogenesis; 2002 Oct; 23(10):1603-7. PubMed ID: 12376467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
